.
MergerLinks Header Logo

New Deal


Announced

The Vistria Group to lead the recapitalization of Medalogix and Muse Healthcare.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

healthcare

Restructuring

Domestic

Majority

Friendly

Pending

United States

data science

Biotechnology

Private

Single Bidder

Acquisition

Merger

machine learning

Synopsis

Edit

The Vistria Group, a Chicago-based investment firm, agreed to lead the recapitalization of Medalogix and Muse Healthcare, two premier data science and machine learning technology companies. In addition to the fusion of Medalogix and Muse, three of the foremost entities in the home health and hospice sectors are minority investors, including LHC Group, Amedisys Home Health and Hospice and Encompass Health. Financial terms were not disclosed. "Integrating our technology with the Medalogix solution platform allows us to cover the entire care continuum for patients in the home, giving our customers the insights and care guidance to obtain the most appropriate outcomes. Together, we will accelerate the growth of our customers, ensuring they are using data to support every care decision, and appropriately increase the days of care provided in the place where the patient deserves to be: their home," Tom Maxwell, Muse Healthcare Chairman and Co-founder.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US